CRISPR Therapeutics AG (CRSP)
50.76
+4.37
(+9.42%)
USD |
NASDAQ |
Nov 01, 16:00
50.80
+0.04
(+0.08%)
After-Hours: 20:00
CRISPR Therapeutics Price: 50.76 for Nov. 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 01, 2024 | 46.96 | 50.85 | 46.91 | 50.76 | 2.231M |
| Oct 31, 2024 | 47.76 | 47.99 | 46.30 | 46.39 | 1.279M |
| Oct 30, 2024 | 48.51 | 49.87 | 47.60 | 47.93 | 1.166M |
| Oct 29, 2024 | 49.53 | 49.75 | 48.44 | 48.94 | 1.185M |
| Oct 28, 2024 | 47.99 | 50.50 | 47.75 | 49.71 | 1.707M |
| Oct 25, 2024 | 47.96 | 48.88 | 47.26 | 47.36 | 1.109M |
| Oct 24, 2024 | 46.19 | 47.98 | 45.92 | 47.95 | 1.105M |
| Oct 23, 2024 | 47.95 | 47.96 | 45.44 | 46.00 | 1.827M |
| Oct 22, 2024 | 48.26 | 48.42 | 47.82 | 48.04 | 834047.0 |
| Oct 21, 2024 | 48.59 | 48.94 | 48.20 | 48.51 | 788699.0 |
| Oct 18, 2024 | 48.55 | 49.24 | 48.40 | 48.92 | 782357.0 |
| Oct 17, 2024 | 48.91 | 49.28 | 48.25 | 48.29 | 1.151M |
| Oct 16, 2024 | 48.32 | 49.25 | 47.90 | 49.00 | 1.005M |
| Oct 15, 2024 | 47.86 | 48.54 | 47.20 | 48.05 | 867986.0 |
| Oct 14, 2024 | 46.74 | 47.88 | 46.10 | 47.82 | 1.046M |
| Oct 11, 2024 | 45.28 | 47.50 | 45.03 | 46.85 | 1.108M |
| Oct 10, 2024 | 45.01 | 45.70 | 44.50 | 45.39 | 576076.0 |
| Oct 09, 2024 | 45.00 | 45.76 | 44.44 | 45.40 | 668821.0 |
| Oct 08, 2024 | 45.08 | 45.39 | 44.60 | 45.20 | 1.039M |
| Oct 07, 2024 | 45.43 | 45.68 | 44.88 | 45.49 | 823485.0 |
| Oct 04, 2024 | 45.53 | 45.80 | 44.61 | 45.37 | 1.134M |
| Oct 03, 2024 | 45.24 | 45.57 | 44.62 | 44.90 | 1.204M |
| Oct 02, 2024 | 45.25 | 45.99 | 44.83 | 45.71 | 927441.0 |
| Oct 01, 2024 | 47.00 | 47.00 | 45.02 | 45.58 | 1.259M |
| Sep 30, 2024 | 46.94 | 47.69 | 46.44 | 46.98 | 926907.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
74.96
Average
63.42
Median
Price Benchmarks
| Vertex Pharmaceuticals Inc | 471.12 |
| AC Immune SA | 3.00 |
| Addex Therapeutics Ltd | 10.70 |
| NLS Pharmaceutics Ltd | 3.60 |
| Molecular Partners AG | 6.12 |
Price Related Metrics
| Price to Book Value | 2.182 |
| Earnings Yield | -6.30% |
| Market Cap | 4.323B |